dexamethasone,carfilzomib,daratumumab
amgen,janssen
['candor']
 dr. from and speaks about the #eha22 abstract - phase 3 candor study , frailty subgroup analysis of with rrmm. #oncotwitter 
Produce, Find, and Distribute the latest and highest quality  multimedia to oncologists, hematologists and researchers.